The rise of epitranscriptomic era: implications for cardiovascular disease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. Regulatory roles of PIWI-interacting RNAs in cardiovascular disease.American journal of physiology. Heart and circulatory physiology · 2025
   Review
2. The functional role of m6A demethylase ALKBH5 in cardiomyocyte hypertrophy.Cell death & disease · 2024
   Article
3. Emerging Role of RNA m5C Modification in Cardiovascular Diseases.Journal of cardiovascular translational research · 2023
   Review
4. PIWI-Interacting RNA HAAPIR Regulates Cardiomyocyte Death After Myocardial Infarction by Promoting NAT10-Mediated acAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
   Article
5. Adenosine-to-inosine Alu RNA editing controls the stability of the pro-inflammatory long noncoding RNA NEAT1 in atherosclerotic cardiovascular disease.Journal of molecular and cellular cardiology · 2021
   Article
6. Role of m6A RNA methylation in cardiovascular disease (Review).International journal of molecular medicine · 2020
   Review
7. The piRNA CHAPIR regulates cardiac hypertrophy by controlling METTL3-dependent NNature cell biology · 2020
   Article
8. N6-adenosine methylation (m6A): a promising new molecular target in hypertension and cardiovascular diseases.Hypertension research : official journal of the Japanese Society of Hypertension · 2020
   Article
9. In search of the mRNA modification landscape in plants.BMC plant biology · 2019
   Review
10. RNA epigenetics and cardiovascular diseases.Journal of molecular and cellular cardiology · 2019
    Review
11. RNA Therapeutics in Cardiovascular Precision Medicine.Frontiers in physiology · 2018
    Review

Corrections and comments

• Comment on
  m(6)A RNA methylation promotes XIST-mediated transcriptional repression.2016

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as